| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |